Option Care Health (NASDAQ:OPCH) Stock Rating Lowered by The Goldman Sachs Group

Option Care Health (NASDAQ:OPCH) was downgraded by equities researchers at The Goldman Sachs Group from a “buy” rating to a “neutral” rating in a research report issued on Monday, FinViz reports. They currently have a $27.00 target price on the stock. The Goldman Sachs Group’s price objective would indicate a potential upside of 13.40% from the company’s previous close.

Several other brokerages have also issued reports on OPCH. Barrington Research cut their target price on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their price target for the company from $38.00 to $26.00 in a report on Thursday. Truist Financial lowered their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday. JMP Securities boosted their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. Finally, Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $30.83.

Option Care Health Stock Down 1.2 %

NASDAQ:OPCH opened at $23.81 on Monday. The firm has a market cap of $4.05 billion, a P/E ratio of 20.24, a P/E/G ratio of 1.74 and a beta of 1.32. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.36 and a current ratio of 1.73. Option Care Health has a fifty-two week low of $22.84 and a fifty-two week high of $34.63. The firm has a 50-day simple moving average of $30.49 and a two-hundred day simple moving average of $29.91.

Insider Buying and Selling

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now owns 21,339 shares in the company, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the transaction, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now owns 21,339 shares in the company, valued at $663,429.51. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Massachusetts Financial Services Co. MA bought a new position in shares of Option Care Health in the second quarter worth about $68,003,000. Magnetar Financial LLC grew its holdings in shares of Option Care Health by 124.8% in the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock worth $68,750,000 after purchasing an additional 1,377,929 shares during the last quarter. Duquesne Family Office LLC grew its holdings in shares of Option Care Health by 172.8% in the second quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company’s stock worth $51,849,000 after purchasing an additional 1,185,613 shares during the last quarter. Hood River Capital Management LLC grew its holdings in shares of Option Care Health by 77.2% in the second quarter. Hood River Capital Management LLC now owns 1,729,029 shares of the company’s stock worth $47,894,000 after purchasing an additional 753,208 shares during the last quarter. Finally, Westfield Capital Management Co. LP grew its holdings in shares of Option Care Health by 15.4% in the first quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock worth $173,448,000 after purchasing an additional 688,653 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.